EPIRUS Biopharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$73.32 K |
Shares Outstanding |
26.18 M |
Public Float |
- |
Address |
699 Boylston Street Boston Massachusetts 02116 United States |
Employees | - |
Website | http://www.epirusbiopharma.com |
Updated | 07/08/2019 |
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company focused on building a pure-play, sustainable and profitable biosimilar business. It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference product. The company was founded on November 26, 2008 and is headquartered in Boston, MA. |